BetterScholar BetterScholar
11
Role
Title
Level Year L/R
๐Ÿœ New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study.
38 auth. F. Cornรฉlis, S. Faurรฉ, Maria Martinez, Jean, Franรงois Prud, homme, Pierre Fritz, C. Dib, H. Alves, P. Barrera, A. Balsa, Dora Pascual, Salcedo, K. Maenaut, R. Westhovens, ... P. Migliorini, Tuyet, Hoa Tran, A. Delaye, N. Prince, C. Lefรฉvre, G. Thomas, Murielle Poirier, S. Soubigou, O. Alibert, S. Lasbleiz, S. Fouix, C. Bouchier, F. Liotรฉ, Marie, Noรซlle Loste, D. Charron, G. Gyapay, Antonio Lopes, Vaz, Daniel Kuntz, T. Bardin, J. Weissenbach
9 1998
9
๐Ÿœ
๐Ÿœ Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages
9 auth. E. Vossenaar, T. Radstake, A. Heijden, M. A. M. V. Mansum, Cindy E. J. Dieteren, D. Rooij, ... P. Barrera, Albert J. W. Zendman, W. Venrooij
8 2004
8
๐Ÿœ
๐Ÿœ Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
8 auth. T. Radstake, M. Roelofs, Y. Jenniskens, Birgitte Oppers-Walgreen, P. V. van Riel, P. Barrera, ... L. Joosten, W. B. van den Berg
8 2004
8
๐Ÿœ
๐Ÿœ IL-32, a proinflammatory cytokine in rheumatoid arthritis.
10 auth. L. Joosten, M. Netea, Soohyun Kim, D. Yoon, Birgitte Oppers-Walgreen, T. Radstake, ... P. Barrera, F. V. D. van de Loo, C. Dinarello, W. B. van den Berg
8 2006
8
๐Ÿœ
๐Ÿœ Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases.
15 auth. A. Zhernakova, B. Alizadeh, M. Bevova, Miek A. van Leeuwen, M. Coenen, B. Franke, L. Franke, M. Posthumus, D. V. van Heel, G. van der Steege, ... T. Radstake, P. Barrera, B. Roep, B. Koeleman, C. Wijmenga
7 2007
7
๐Ÿœ
๐Ÿฆ Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis.
10 auth. P. Barrera, A. Blom, P. V. Lent, L. Bloois, J. Beijnen, N. Rooijen, ... M. D. W. Malefijt, L. V. D. Putte, G. Storm, W. B. Berg
7 2000
7
๐Ÿฆ
๐Ÿฌ Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis
C. Popa, M. Netea, T. Radstake, P. Riel, P. Barrera, J. Meer
7 2005
7
๐Ÿฌ
๐Ÿข Long term anti-tumour necrosis factor ฮฑ monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation
12 auth. A. D. Broeder, L. Joosten, T. Saxne, D. HeinegaฬŠrd, H. Fenner, A. Miltenburg, ... W. Frasa, L. V. Tits, W. Buurman, P. Riel, L. B. A. Putte, P. Barrera
7 2002
7
๐Ÿข
๐Ÿข Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis
10 auth. C. Popa, F. V. D. van den Hoogen, T. Radstake, M. Netea, A. Eijsbouts, M. Heijer, ... J. V. D. van der Meer, P. V. van Riel, A. Stalenhoef, P. Barrera
7 2007
7
๐Ÿข
๐Ÿœ Successful Treatment of Dermatomyositis and Polymyositis with Anti-Tumor-Necrosis-Factor-Alpha: Preliminary Observations
7 auth. G. Hengstman, F. V. D. Hoogen, P. Barrera, M. Netea, A. Pieterse, L. Putte, ... B. Engelen
7 2003
7
๐Ÿœ
๐Ÿœ The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome.
9 auth. T. Radstake, B. Franke, S. Hanssen, M. Netea, P. Welsing, P. Barrera, ... L. Joosten, P. V. van Riel, W. B. van den Berg
7 2004
7
๐Ÿœ